Gene-Sequencing Company Illumina to Sell Cancer Test Developer

The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.

source https://www.nytimes.com/2023/12/17/business/media/illumina-cancer-detector-sale.html